CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies

GETAS THREAT LEVEL: GUARDED
TOP DONOR: BRIAN CARTMELL
#2 DONOR: DONALD MACLEAN
#3 DONOR: JEFF BONE/TOPSIGHT FUND
#4 DONOR: PEG KAY

LF FUND: $592,642.68
BITCOIN ENDOWMENT: $5,379,019.19
A-PRIZE: $30,011.00
NANOSHIELD: $17,018.00
X-RISKS NETWORK: $3,104.00
AISHIELD: $4,110.00

LIFEBOAT NEWS: 2,849 SUBSCRIBERS
GETAS ALERTS: 418 SUBSCRIBERS
BLOG: 40,114 POSTS
BOARDS: 2,818 MEMBERS
REPORTS: 55
PROGRAMS: 25
FORUMS: 13
QUOTES: 136

FACEBOOK: 8,341 MEMBERS
LINKEDIN: 1,291 MEMBERS
TWITTER FEED: 34,010 MEMBERS
FIGHT AIDS: 2 MEMBERS
[email protected]: 15 MEMBERS
[email protected]: 40 MEMBERS
A-PRIZE: 55 MEMBERS
NANOSHIELD: 69 MEMBERS
AISHIELD: 25 MEMBERS

DONORS: 3,358
LF-500: 13 MEMBERS
PATRON: 1 MEMBER
FIRST CLASS: 1 MEMBER
EXECUTIVE: 12 MEMBERS
ECONOMY: 23 MEMBERS
A-500: 1 MEMBER

© 2002–2020 Lifeboat Foundation